Full-Year 2018 Galafold Revenue of ~$91M Exceeds $80M-$90M Guidance 2019 Galafold Revenue Expected to Nearly Double – with Guidance of $160M-$180M Pompe Phase 3 PROPEL Study Expected to Complete Enrollment and Additional Phase 2 Pompe Data in 2019 …
LIQ861 was well-tolerated in PAH patients at two-weeks of treatment, the safety endpoint requested by U.S. FDA NDA submission targeted for late 2019 RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) …
SAN FRANCISCO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today …
MCLA-145 is a full-length human bispecific antibody binding to PD-L1 and CD137 UTRECHT, The Netherlands, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length …
RICHMOND, Va., Jan. 07, 2019 (GLOBE NEWSWIRE) -- The Brink’s Company (NYSE:BCO), the global leader in total cash management, route-based secure logistics and payment solutions, today announced that it has completed its acquisition of Brazil-based Rodoban …
SAN DIEGO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that, based on preliminary and unaudited financial data, the Company expects net product sales for the fourth quarter of 2018 to be approximately $44 million. For …
– Expanding the Label for TIBSOVO®: Supplemental New Drug Application (sNDA) Submitted for TIBSOVO® as Monotherapy for Patients with Newly Diagnosed AML with an IDH1 Mutation Ineligible for Standard Therapy; Approval Expected in 2019 – – IDH1m Solid Tumor …
TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia” or the “Company”) has completed Phase I construction and retrofitting of its Niagara Greenhouse facility (“Niagara”) located in Grimsby, Ontario. …
REDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- The LUNAR assay, a new blood-based assay intended to detect early-stage cancer and recurrence of disease, is now available from Guardant Health, Inc. (Nasdaq:GH), for research use by biopharmaceutical …
BERKELEY HEIGHTS, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell …
Proof of concept that new class of lysin biologics has the potential to improve treatment outcomes in serious bacterial infections Exebacase demonstrated robust safety and tolerability profile Company intends to progress exebacase to Phase 3 Conference …
DALLAS, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Real-time, comprehensive data is critical to a successful live event, but having a holistic system to capture and examine that information has been an ongoing industry challenge. Freeman® — the world’s leading …
Achieves 2018 revenue of between $471 million and $476 million, including approximately 28% growth in Feraheme® (ferumoxytol injection) sales Acquisition of two development-stage assets creates a strong and diversified portfolio, leveraging therapeutic …
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare …
Top-line data from the interim analysis of the Phase 3 REGENERATE trial of obeticholic acid (OCA) in nonalcoholic steatohepatitis (NASH) patients with advanced fibrosis anticipated in Q1 2019 Phase 3 REVERSE trial of OCA in NASH patients with compensated …
PISCATAWAY, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Hammer Fiber Optics Holdings Corp (OTCQB: HMMR) and Wikibuli, Inc. announce today that the transaction between the companies closed as planned on January 1, 2019. As part of the agreement Hammer Wireless …
BOSTON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- ClearCompany today announced the availability of the ClearCompany Bi-Directional Connector for ADP Workforce Now®. This is the first integration that automatically synchs employee data between the two platforms. …
Rockville, MD, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Polyphenylene sulfide (PPS) resins consumption is likely to surpass 93.7 thousand tons in 2019, according to Fact.MR’s new study. The polyphenylene sulfide (PPS) resins market grew at a 5.3% in 2018, with …
After four years of untiring commitment and dedication, Maurizio Arrivabene is leaving the team. The decision was taken together with the company’s top management after lengthy discussions related to Maurizio’s long term personal interests as well as those …
DENVER, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Glowpoint, Inc. (NYSE American: GLOW) (“Glowpoint” or the “Company”), a managed service provider of video collaboration and network applications, announced today that the NYSE American LLC (“NYSE American” or the “ …
06 days 02:53:58
